GENE ONLINE|News &
Ultrasound Transducer for Combined Histotripsy Breaks Down Cancer Tumors
A team of engineers at the University of Michigan College of Engineering has developed a new non-invasive ultrasound technology called histotripsy, using ultrasound transducers that mechanically destroy liver tumors in mice through ultrasound waves with high precision. The study results showed that ultrasound therapy not only effectively killed 50-75% of cancer cells, but also activated the immune system in mice, reducing the risk of cancer recurrence or metastasis by about 81%.
It's free! Log in now to read
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
